Loading clinical trials...
Loading clinical trials...
Eligible candidates will be adults with aggressive or very aggressive NHL (WHO classification diagnosis confirmed by histological tumor examination). Patients must have failed one or more prior NHL ch...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
NCT07249528 · Non-hodgkin Lymphoma, Multiple Myeloma
NCT06386315 · Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent B-Cell Non-Hodgkin Lymphoma, and more
NCT03223610 · Lymphoma, Non-Hodgkin Lymphoma, and more
NCT05909059 · Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, and more
NCT06090539 · Relapsed/Refractory Non-Hodgkin Lymphoma
Jefferson-Myrna Brind Center of Integrative Medicine
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions